Delphi VC

Investor type Venture Capital
Founders Kalika Farmer Pip Deely


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 7
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Food and Beverage
  • Medical
  • FinTech
  • Cultivation

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Delphi VC:
Typical Co-investors
Delphi VC is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Delphi VC:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Fen Xin Investment Management Beijing, Beijing, China
Building Blocks -
Chongqing Dongzheng Huaixin Guquan Touzi Jijin Hehuo Qiye (Youxian Hehuo) China, Chongqing, Jiulongpo
Cogito Ventures -
Elm -
Full Tilt Capital California, San Diego, United States
Guangdong Hongmi Touzi Hehuo Qiye (Putong Hehuo) China, Guangdong, Zhangshan
Huiming Touzi China, Shanghai
Invest In Visions -
Irelandia Investments County Dublin, Dublin, Ireland
Maroon Bells Capital Partners California, San Francisco, United States
MF Private Capital Boston, Massachusetts, United States
Opium Ventures China, Hong Kong, Hong Kong Island
PTEK Ventures Atlanta, Georgia, United States
Ruian Real Estate Development Management China, Shanghai
Shinhan Capital Seoul, Seoul-t'ukpyolsi, South Korea
Societe Generale France, Ile-de-France, Paris
SuRo Capital California, San Francisco, United States
Taleria Ventures -
Yizheng Ziben China, Guangdong, Tianjin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Food and Beverage
Other Agriculture
$25M20 Aug 2021 New York, New York, United States

Beckley Psytech

Health Care
$79M15 Aug 2021 South Oxfordshire, England, United Kingdom

Caravan Wellness

Health Care
01 Jan 2021 New York, New York, United States

Parsley Health

Health Care
Health Diagnostics
20 Oct 2019 New York, United States

Parsley Health

Health Care
Health Diagnostics
$26M10 Oct 2019 New York, New York, United States

Good Money

Financial Services
Mobile Apps
$30M10 Dec 2018 Los Angeles, California, United States


Food and Beverage
Other Agriculture
01 Jul 2018 New York, United States


Big Data
Business Intelligence
Data Visualization
15 Jun 2018 New York, New York, United States

Imperfect Foods

Delivery Service
Food and Beverage
Food Delivery
$5M07 Jan 2018 San Francisco, California, United States
Beckley Psytech Closes $80M Series B Funding

– Beckley Psytech an Oxford, England-based private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines closed an $80m Series B financing.
– The round was led by Integrated with participation from Prime Movers Labs, Adage Capital Management, Palo Santo; Delphi VC; Leafy Tunnel; Negev Capital; and existing investor Bicycle Day Ventures.
– The company intends to use the funds to complete the ongoing Phase 1b trial with low-dose psilocybin in patients suffering from SUNHA, a rare and debilitating headache condition estimated to affect 45,000 people in the US and Europe, and to initiate a Phase 1 dose-ranging study on a novel formulation of intranasal 5-MeO-DMT before starting a Phase 2 trial in Treatment Resistant Depression, and expand its pipeline with new, unique and proprietary psychedelic compounds.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Delphi VC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: